Yesilipek A - Search Results

1

Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study.

Bader P, Pötschger U, Dalle JH, Moser LM, Balduzzi A, Ansari M, Buechner J, Güngör T, Ifversen M, Krivan G, Pichler H, Renard M, Staciuk R, Sedlacek P, Stein J, Heusel JR, Truong T, Wachowiak J, Yesilipek A, Locatelli F, Peters C. Bader P, et al. Among authors: yesilipek a. Blood Adv. 2024 Jan 23;8(2):416-428. doi: 10.1182/bloodadvances.2023010591. Blood Adv. 2024. PMID: 37738088 Free PMC article. Clinical Trial.

2

Compound heterozygosity for two beta chain variants: the mildly unstable Hb Tyne (codon 5 Pro→Ser) and HbS (codon 6 Glu→Val).

Güzeloğlu Kayışlı Ö, Keser İ, Özeş ON, Canatan D, Yeşilipek A, Lüleci G. Güzeloğlu Kayışlı Ö, et al. Among authors: yesilipek a. Turk J Haematol. 2005 Mar 5;22(1):37-40. Turk J Haematol. 2005. PMID: 27264516 English.

3

Two rare mutations in Turkey: IVS I.130(G-C) and IVS II.848(C-A).

Nal N, Manguoglu AE, Sargin CF, Keser I, Kupesiz A, Yesilipek A, Luleci G. Nal N, et al. Among authors: yesilipek a. Clin Lab Haematol. 2005 Aug;27(4):274-7. doi: 10.1111/j.1365-2257.2005.00691.x. Clin Lab Haematol. 2005. PMID: 16048497

4

Combination of Hb Knossos [Cod 27 (G-T)] and IVSII-745 (C-G) in a Turkish patient with beta-thalassemia major.

Keser I, Manguoglu E, Kayisli O, Yesilipek A, Luleci G. Keser I, et al. Among authors: yesilipek a. Genet Test. 2007 Fall;11(3):228-30. doi: 10.1089/gte.2006.0521. Genet Test. 2007. PMID: 17949282

5

Complementary and alternative medicine use in children with thalassaemia.

Efe E, Işler A, Sarvan S, Başer H, Yeşilipek A. Efe E, et al. Among authors: yesilipek a. J Clin Nurs. 2013 Mar;22(5-6):760-9. doi: 10.1111/j.1365-2702.2012.04210.x. Epub 2012 Aug 21. J Clin Nurs. 2013. PMID: 22906056

6

The phenotypic effect of Hb G-Coushatta [beta22 (B4) Glu-Ala] and association with IVS.II.1(G-A) in a Turkish family.

Sargin CF, Nal N, Manguoglu AE, Keser I, Mendilcioglu I, Yesilipek A, Luleci G. Sargin CF, et al. Among authors: yesilipek a. Genet Couns. 2005;16(3):307-8. Genet Couns. 2005. PMID: 16259329 No abstract available.

7

Embryonic rhabdomyosarcoma presenting as endobronchial tumor in an adolescent.

Tezcan G, Küpesiz A, Yesilipek A, Hazar V, Aksu GD, Ozkaynak C, Ozbilim G. Tezcan G, et al. Among authors: yesilipek a. Pediatr Blood Cancer. 2005 Jun 15;44(7):689-90. doi: 10.1002/pbc.20324. Pediatr Blood Cancer. 2005. PMID: 15702484 No abstract available.

8

Clinical importance of circulating and cellular expression levels of Fas and Fas ligand in pediatric patients with lymphoproliferative malignancies.

Hazar V, Berber Z, Pestereli E, Coskun M, Yesilipek A, Karpuzoglu G, Yegin O. Hazar V, et al. Among authors: yesilipek a. Pediatr Hematol Oncol. 2005 Apr-May;22(3):247-56. doi: 10.1080/08880010590921621. Pediatr Hematol Oncol. 2005. PMID: 16020109

9

The effect of HBB: c.*+96T>C (3'UTR +1570 T>C) on the mild b-thalassemia intermedia phenotype.

Bilgen T, Canatan D, Arıkan Y, Yeşilipek A, Keser İ. Bilgen T, et al. Among authors: yesilipek a. Turk J Haematol. 2011 Sep 5;28(3):219-22. doi: 10.5152/tjh.2011.57. Turk J Haematol. 2011. PMID: 27264370 English.

10

Plasma homocysteine levels in patients with beta-thalassaemia major.

Ozdem S, Kupesiz A, Yesilipek A. Ozdem S, et al. Among authors: yesilipek a. Scand J Clin Lab Invest. 2008;68(2):134-9. doi: 10.1080/00365510701516343. Scand J Clin Lab Invest. 2008. PMID: 18382931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters